References
Klimek, J., Marsik, F., Bartlett, R. C., Weir, B., Shea, P., Quintiliani, R.: Clinical, epidemiologic and bacteriologicStaphylococcus aureus in a large community hospital. American Journal of Medicine 1976, 61: 340–345.
Crossley, K., Loesch, D., Landesman, B., Mead, K., Chern, M., Strate, R.: An outbreak of infections caused by strains ofStaphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies. Journal of Infectious Diseases 1979, 139: 273–279.
Karchmer, A. W., Archer, G. L., Dismukes, W.:Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Annals of Internal Medicine 1983, 98: 477–485.
Farber, B. F., Moellering, R. C.: Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrobial Agents and Chemotherapy 1983, 23: 138–141.
Krogstad, D. J., Moellering, R. C., Greenblatt, D. J.: Single dose kinetics of intravenous vancomycin. Journal of Clinical Pharmacology 1980, 20: 197–201.
Moellering, R. C., Krogstad, D. J., Greenblatt, D. J.: Vancomycin therapy in patients with impaired renal function: a nomogram for dosage. Annals of Internal Medicine 1981, 94: 343–346.
Magera, B. E., Arroyo, J. C., Rosansky, S. J., Postic, B.: Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis. Antimicobial Agents Chemotherapy 1983, 23: 710–714.
Moellering, R. C., Krogstad, D. J., Greenblatt, D. J.: Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function. Reviews of Infectious Diseases 1981, 3: S. 230–235.
Farber, B. F., Karchmer, A. W., Buckley, M., Moellering, R. C.: Vancomycin prophylaxis during cardiac operations. Determination of an optimal dose. Journal of Thoracic and Cardiovascular Surgery 1983, 85: 933–935.
Morris, A. J., Bilinsky, R. T.: Prevention of staphylococcal shunt infections by continuous vancomycin prophylaxis. American Journal of Medical Science 1971, 262: 87–92.
American Heart Association Committee on Prevention of Bacterial Endocarditis: Prevention of bacterial endocarditis. Circulation 1977, 56: 139A.
Newfield, P., Rolzen, M. F.: Hazards of rapid administration of vancomycin. Annals Internal Medicine 1979, 89: 4.
Watanakunakorn, C.: Treatment of infections due to methicillin resistantStaphylococcus aureus. Annals of Internal Medicine 1982, 97: 376–378.
Lowy, F. D., Chang, D. S., Lash, P. R.: Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin resistant coagulase negative staphylococci. Antimicrobial Agents and Chemotherapy 1983, 23: 932–934.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Farber, B.B. Vancomycin: Renewed interest in an old drag. Eur. J, Clin. Microbiol. 3, 1–3 (1984). https://doi.org/10.1007/BF02032805
Issue Date:
DOI: https://doi.org/10.1007/BF02032805